Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab.

Literature DB >> 28350581

Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab.

Gwenaëlle Le Garff¹, Assia Samri, Sidonie Lambert-Niclot, Sophie Even, Armelle Lavolé, Jacques Cadranel, Jean-Philippe Spano, Brigitte Autran, Anne-Geneviève Marcelin, Amélie Guihot.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2017 PMID： 28350581 DOI： 10.1097/QAD.0000000000001429

Source DB: PubMed Journal: AIDS ISSN： 0269-9370 Impact factor: 4.177

Keyword Cloud
Cited

× No keyword cloud information.

37 in total

1. Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection.

Authors: E P Scully; R L Rutishauser; C R Simoneau; H Delagrèverie; Z Euler; C Thanh; J Z Li; H Hartig; S Bakkour; M Busch; G Alter; F M Marty; C-C Wang; S G Deeks; J Lorch; T J Henrich
Journal: Ann Oncol Date: 2018-10-01 Impact factor: 32.976

Review 2. CD4⁺ T Cell Differentiation in Chronic Viral Infections: The Tfh Perspective.

Authors: Laura A Vella; Ramin S Herati; E John Wherry
Journal: Trends Mol Med Date: 2017-11-12 Impact factor: 11.951

Review 3. Immunologic Control of HIV-1: What Have We Learned and Can We Induce It?

Authors: Daniel C Rogan; Mark Connors
Journal: Curr HIV/AIDS Rep Date: 2021-03-11 Impact factor: 5.071

Review 4. Advances toward Curing HIV-1 Infection in Tissue Reservoirs.

Authors: Lisa J Henderson; Lauren B Reoma; Joseph A Kovacs; Avindra Nath
Journal: J Virol Date: 2020-01-17 Impact factor: 5.103

5. Nivolumab Treatment for Cancers in the HIV-infected Population.

Authors: Elaine Chang; Anita L Sabichi; Jennifer R Kramer; Christine Hartman; Kathryn E Royse; Donna L White; Niraj R Patel; Peter Richardson; Sarvari V Yellapragada; Jose M Garcia; Elizabeth Y Chiao
Journal: J Immunother Date: 2018-10 Impact factor: 4.456

6. CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption.

Authors: Justin Harper; Shari Gordon; Chi Ngai Chan; Hong Wang; Emily Lindemuth; Cristin Galardi; Shane D Falcinelli; Samuel L M Raines; Jenna L Read; Kevin Nguyen; Colleen S McGary; Michael Nekorchuk; Kathleen Busman-Sahay; James Schawalder; Colin King; Maria Pino; Luca Micci; Barbara Cervasi; Sherrie Jean; Andrew Sanderson; Brian Johns; A Alicia Koblansky; Heather Amrine-Madsen; Jeffrey Lifson; David M Margolis; Guido Silvestri; Katharine J Bar; David Favre; Jacob D Estes; Mirko Paiardini
Journal: Nat Med Date: 2020-03-16 Impact factor: 53.440

Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab.

1. Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection.

Review 2. CD4⁺ T Cell Differentiation in Chronic Viral Infections: The Tfh Perspective.

Review 3. Immunologic Control of HIV-1: What Have We Learned and Can We Induce It?

Review 4. Advances toward Curing HIV-1 Infection in Tissue Reservoirs.

5. Nivolumab Treatment for Cancers in the HIV-infected Population.

6. CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption.

Review 7. Cancer immunotherapy of patients with HIV infection.

8. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.

Review 9. So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research.

Review 10. Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review.

Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab.

1. Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection.

Review 2. CD4+ T Cell Differentiation in Chronic Viral Infections: The Tfh Perspective.

Review 3. Immunologic Control of HIV-1: What Have We Learned and Can We Induce It?

Review 4. Advances toward Curing HIV-1 Infection in Tissue Reservoirs.

5. Nivolumab Treatment for Cancers in the HIV-infected Population.

6. CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption.

Review 7. Cancer immunotherapy of patients with HIV infection.

8. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.

Review 9. So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research.

Review 10. Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review.

Review 2. CD4⁺ T Cell Differentiation in Chronic Viral Infections: The Tfh Perspective.